A lotion formulation of Differin, the popular prescription acne treatment, has been approved by the U.S. FDA and should be available for prescription in April 2010.
Adapalene, the active ingredient of Differin, is a topical retinoid. Topical retinoids are a category of dermatology medication derived from vitamin A. They are a fundamental component of acne therapy and have also been shown to be safe and effective for the treatment of psoriasis and aging skin.
Differin has been available as a 0.1% gel, a 0.1% cream and a 0.3% gel. The new lotion is formulated for efficacy, tolerability and spreads easily. It will be available in a convenient, easy-to-use pump dispenser.
Like other topical retinoids, Differin may be prescribed for use alone or in combination with other acne medications, particularly for cases of moderate acne or severe acne.
